PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice
BackgroundThe transcriptional factor peroxisome proliferator–activated receptor γ (PPARγ) is an important therapeutic target for the treatment of type 2 diabetes. However, the role of the PPARγ transcriptional activity remains ambiguous in its metabolic regulation.MethodsBased on the crystal structu...
Main Authors: | Fusheng Guo, Shuangshuang Xu, Yanlin Zhu, Xing Zheng, Yi Lu, Jui Tu, Ying He, Lihua Jin, Yong Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.01285/full |
Similar Items
-
PPARγ Acetylation in Adipocytes Exacerbates BAT Whitening and Worsens Age-Associated Metabolic Dysfunction
by: Ying He, et al.
Published: (2023-05-01) -
Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
by: Xinni Xie, et al.
Published: (2017-05-01) -
Shockwaves Suppress Adipocyte Differentiation via Decrease in PPARγ
by: Wonkyoung Cho, et al.
Published: (2020-01-01) -
Microsecond MD Simulations to Explore the Structural and Energetic Differences between the Human RXRα-PPARγ vs. RXRα-PPARγ-DNA
by: Faizul Azam, et al.
Published: (2022-09-01) -
Sulfonylureas exert antidiabetic action on adipocytes by inhibition of PPARγ serine 273 phosphorylation
by: Bodo Haas, et al.
Published: (2024-07-01)